ARTELO BIOSCIENCES, INC. financial data

Symbol
ARTL on Nasdaq
Location
Solana Beach, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 24 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 35% % -93%
Debt-to-equity -662% % -3966%
Return On Equity 1937% %
Return On Assets -345% % -168%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2,124,772 shares -35%
Common Stock, Shares, Outstanding 2,018,746 shares 256%
Entity Public Float $9,288,602 USD 117%
Common Stock, Value, Issued $2,000 USD 100%
Weighted Average Number of Shares Outstanding, Diluted 1,029,000 shares 92%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $5,423,000 USD -9.5%
General and Administrative Expense $5,981,000 USD 45%
Operating Income (Loss) $11,404,000 USD -13%
Nonoperating Income (Expense) $1,475,000 USD -623%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $12,879,000 USD -31%
Earnings Per Share, Diluted -12.52 USD/shares 32%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $600,000 USD
Marketable Securities, Current $0 USD -100%
Assets, Current $695,000 USD -73%
Operating Lease, Right-of-Use Asset $64,000 USD -35%
Intangible Assets, Net (Excluding Goodwill) $2,039,000 USD 0%
Assets $2,801,000 USD -40%
Accrued Liabilities, Current $11,000 USD
Liabilities, Current $4,044,000 USD 128%
Operating Lease, Liability, Noncurrent $29,000 USD -58%
Liabilities $4,073,000 USD 121%
Accumulated Other Comprehensive Income (Loss), Net of Tax $272,000 USD -35%
Retained Earnings (Accumulated Deficit) $63,015,000 USD -26%
Stockholders' Equity Attributable to Parent $1,272,000 USD -145%
Liabilities and Equity $2,801,000 USD -40%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,597,000 USD 46%
Net Cash Provided by (Used in) Financing Activities $0 USD -100%
Net Cash Provided by (Used in) Investing Activities $0 USD -100%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 2,018,746 shares 256%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,592,000 USD 1.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $600,000 USD -74%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Deferred Tax Assets, Valuation Allowance $7,817,000 USD 38%
Operating Lease, Liability $87,000 USD 1350%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $12,949,000 USD -32%
Operating Lease, Liability, Current $40,000 USD 14%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 69,444 shares 0%
Additional Paid in Capital $62,013,000 USD 17%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Interest Expense $111,000 USD
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%